3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Neoplasms
16
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
8
Neoplasm Metastasis
7
Lung Neoplasms
7
Lymphoma
6
Hematologic Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Multiple Myeloma
5
Glioblastoma
5
Stomach Neoplasms
4
Leukemia
4
Fatigue
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Fallopian Tube Neoplasms
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Interventions
Bupivacaine
11
Ketamine
9
Ropivacaine
8
Morphine
8
Acetaminophen
8
Fentanyl
7
Dexmedetomidine
7
Lidocaine
6
Anesthesia, General
6
Analgesics, Opioid
6
Saline Solution
5
Anesthesia, Local
5
Acupuncture Therapy
5
parecoxib
4
Tramadol
4
Sodium Chloride
4
Pregabalin
4
Ethanol
4
Analgesia, Epidural
4
Transcutaneous Electric Nerve Stimulation
3
Radiofrequency Ablation
3
Propofol
3
Oxycodone
3
Ketorolac
3
Control Groups
3
Anesthetics, Local
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
Therapeutics
2
Surveys and Questionnaires
2
Magnesium Sulfate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Agnosia
×
Palliative Care
×
Clear all
NCT06555588
2026-03-16
Engage
Duke University
Phase NA
Recruiting
190 enrolled